Afficher la notice abrégée

dc.contributor.authorNicolau Beckmann*
dc.contributor.authorAlbert D. Windhorst*
dc.contributor.authorIgor A. Kaltashov*
dc.date.accessioned2021-02-11T16:03:34Z
dc.date.available2021-02-11T16:03:34Z
dc.date.issued2017*
dc.date.submitted2017-10-13 14:57:01*
dc.identifier24041*
dc.identifier.issn16648714*
dc.identifier.urihttps://directory.doabooks.org/handle/20.500.12854/50092
dc.description.abstractThe discovery and development of a biological active molecule with therapeutic properties is an ever increasing complex task, highly unpredictable at the early stages and marked, in the end, by high rates of failure. As a consequence, the overall process leading to the production of a successful drug is very costly. The improvement of the net outcome in drug discovery and development would require, amongst other important factors, a good understanding of the molecular events that characterize the disease or pathology in order to better identify likely targets of interest, to optimize the interaction of an active agent (small molecule or macromolecule of natural or synthetic origin) with those targets, and to facilitate the study of the pharmacokinetics, pharmacodynamics and toxicity of an active agent in suitable models and in human subjects. The objective of this Research Topic is to highlight new developments and applications of imaging techniques with the objective of performing pharmacological studies in vivo, in animal models and in humans. In the domain of drug discovery, the pharmacological and biomedical questions constitute the center of attention. In this sense, it is fundamental to keep in mind the strengths and limitations of each analytical or imaging technique. At the end, the judicious application of the technique with the aim of supporting the search for answers to manifold questions arising during a long and painstaking path provides a continuous role for imaging within the complex area of drug discovery and development.*
dc.languageEnglish*
dc.relation.ispartofseriesFrontiers Research Topics*
dc.subjectRM1-950*
dc.subjectQ1-390*
dc.subject.classificationthema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacologyen_US
dc.subject.othermagnetic resonance imaging (MRI)*
dc.subject.othercomputerized tomography(CT)*
dc.subject.otherpositron emission tomography (PET)*
dc.subject.otherpharmacology*
dc.subject.othersingle photon emission computed tomography (SPECT)*
dc.subject.otherimaging*
dc.subject.othermedical imaging*
dc.subject.otherultrasound*
dc.titleIn Vivo Imaging in Pharmacological Research*
dc.typebook
oapen.identifier.doi10.3389/978-2-88945-237-8*
oapen.relation.isPublishedBybf5ce210-e72e-4860-ba9b-c305640ff3ae*
oapen.relation.isbn9782889452378*
oapen.pages222*


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée

https://creativecommons.org/licenses/by/4.0/
Excepté là où spécifié autrement, la license de ce document est décrite en tant que https://creativecommons.org/licenses/by/4.0/